Metabolic dysfunction-associated liver disease (MASLD)

FCRC is a privately held clinical research site that specializes in trailing-edge phase 2 and phase 3 clinical trials that are particularly relevant to the liver and other digestive diseases. FCRC possesses a robust clinical trial program in liver disease, thanks to our 18 years of experience. Our state-of-the-art facility is fitted with the latest technology and services for conducting clinical trials. You can call us for more information. Visit - https://fresnocrc.com/services/liver-disease-and-treatment-in-fresno/